Financial and Operational Update on $45.5m Contract - ANSTO

Key points

• Client confirmed as ANSTO, Australian Nuclear Science and Technology Organisation
• Project part of ANSTO's Nuclear Medicine Manufacturing Program
• Expected to contribute over 2.4 times Synertec Engineering's FY26 revenue

Full summary

Synertec Corporation Ltd (ASX: SOP) has been awarded a significant $45.5 million engineering services contract by the Australian Nuclear Science and Technology Organisation (ANSTO). The project, part of ANSTO's Nuclear Medicine Manufacturing Program, involves the design and integration of a new Nuclear Medicine Manufacturing Facility at Lucas Heights, NSW. Synertec will lead process design and integration, ensuring compliance with stringent pharmaceutical, radiological, and regulatory standards. The contract is expected to contribute significantly to Synertec's FY27 revenue, with approximately $36 million to be recognized during the initial 26-month design phase. The project is also anticipated to enhance Australia's sovereign capability in nuclear medicine manufacturing and secure the long-term supply of critical healthcare products.

Guidance

FY27 revenue guidance to be updated as project execution profile becomes clearer

Outlook

Synertec expects the ANSTO contract to have a favourable impact on FY27 revenue, pending further assessment.